marcus evans north america conferences

11th Product Selection & Pipeline Optimization for Generics

Optimizing Product Selection and Business Development Opportunities to Maintain Competitive Advantage and Achieve Highest Portfolio Performance

12-13 Sep 2018
Renaissance Philadelphia Airport Hotel | Philadelphia, PA, United States of America

Why You Should Attend

11th Product Selection & Pipeline Optimization for Generics

This 11th installment of the marcus evans Product Selection & Portfolio Optimization event will bring together key players in the Generics industry from a variety of roles to discuss strategies and best practices in forging new business opportunities and selecting the right product portfolio to win market opportunities at the right time to drive growth and expansion globally. This two day conference will combine a variety of content rich presentations, as well as, numerous networking and discussion opportunities to forge new relationships, identify potential partners, and capitalize on new opportunities to drive business success.

To download the agenda, please click here.

Key Topics

  • Strengthen product selection framework to enhance performance in line with portfolio initiatives
  • Build strategic partnership and licensing agreements to maximize portfolio capacity and ROI
  • Design a robust product rationalization process to predict product viability and success
  • Optimize portfolio management to ensure and maintain speed to market
  • Keep pace with the fast-paced generics market to achieve a competitive advantage and market exclusivity
  • Previous Attendees Include

    Aiping Pharmaceuticals, Albemarle Corp, Alcami Corporation, Amneal Pharmaceuticals, Apotex Inc., Arent Fox LLP, Bachem Americas, Breckenridge Pharma, Camargo Pharmaceutical, Canda Pharmaceuticals, CIPLA, Coldstream Labs, CPL, EZRA Ventures LLC, Federal Trade Commission Health Care Division, Fresenius Kabi USA LLC, G&W Laboratories, Goodwin Procter, Greenstone LLC, Handa Pharmaceuticals LLC, Impax Laboratories, Johnson Matthey Inc, Klus Pharma Inc, Lehigh Valley Technologies, Lupin Pharmaceuticals Inc, Lupin Somerset, Mallinckrodt Pharmaceuticals, Mayne Pharma, MSN Pharma, Noramco Inc, Office of Generic Drugs CDER FDA, PAR Pharmaceuticals, Pharmascience Inc. ,Pharmathen UK , Procos S.p.A (CBC Group), PuraCap Pharmaceutical, Renaissance Pharma, Sandoz Inc., Saptalis Pharmaceuticals LLC, Sigmapharm Laboratories, Stason Pharmaceuticals, Sun Pharmaceuticals, Teva API Inc, Torrent Pharma, United States Pharmacopeia, Upsher-Smith Laboratories Inc., Wockhardt USA LLC

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Sponsors
    Amin Talati Upadhye
    Visit website >>

    Event Partners

    Practical Insights From

    Gaurav Jain, MBA
    Vice President, Commercial & Business Development
    Appco Pharma LLC

    Doug Williams
    Vice President, Strategic Partnerships
    Ascendia Pharmaceuticals

    Erika Geimonen, Ph.D.
    Vice President, Business Development
    Amring Pharmaceuticals

    Sami Yusuf, Pharm. D., M.S., MBA
    Vice President, Strategy & Development Portfolio Corporate Development Department
    Upsher-Smith Laboratories

    Richard A. Hoyt
    Vice President, Business Development and Licensing
    Mallinckrodt Pharmaceuticals

    Xinyu (Tom) Huang, Ph.D.
    Senior Director, Novel Drug Delivery Technologies
    Luye Pharma Group Ltd.

    Michael Roy
    Director, International Sales & Business Development of Generics
    Mallinckrodt Pharmaceuticals

    Dennis Dong
    Associate Director, Biologics, Assays, & Tech
    Teva Pharmaceuticals

    Click Here For Full Agenda

    Voice of Our Customers
    • “Well organized, great topics and the interactions were fantastic. Looking forward to more!” – Teva Pharmaceuticals
    • “Always great speakers and content.” Thank you!” – West Ward Pharmaceuticals
    • “Being new to the industry, networking and learning from the presenters was eye opening.” – Sun Pharma
    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    John Hummel

    NBC Tower, 9th Floor
    455 North Cityfront Plaza Drive
    Chicago, IL 60611

    312-540-3000 Ext: 6327
    Fax: 312.894.6304